CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 2.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,564,915 | -26.7% | 283,416 | -12.8% | 0.00% | – |
| Q2 2023 | $3,497,936 | +106.0% | 325,087 | +95.9% | 0.00% | – |
| Q1 2023 | $1,697,648 | -28.5% | 165,948 | -26.3% | 0.00% | – |
| Q4 2022 | $2,373,940 | -35.8% | 225,018 | -21.9% | 0.00% | -100.0% |
| Q3 2022 | $3,696,000 | -16.6% | 288,280 | -16.6% | 0.00% | 0.0% |
| Q2 2022 | $4,430,000 | -15.0% | 345,543 | -30.6% | 0.00% | 0.0% |
| Q1 2022 | $5,213,000 | +2.5% | 497,875 | +51.1% | 0.00% | 0.0% |
| Q4 2021 | $5,084,000 | +217.9% | 329,456 | +365.3% | 0.00% | – |
| Q3 2021 | $1,599,000 | -6.4% | 70,799 | +6.7% | 0.00% | – |
| Q2 2021 | $1,709,000 | +10581.2% | 66,349 | +17133.5% | 0.00% | – |
| Q1 2021 | $16,000 | – | 385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |